B7-H3Bi-Ab-ATC have the capability to eliminate B7-H3-positive bladder cancer cells through the CD3-B7-H3 bridge mechanism, exhibiting significant cytotoxic activity against human bladder cancer cells. This evidence concerns the gene CD276 and urinary bladder cancer.